Concepedia

Christopher McCann

CM

Statistics

Publications

15

Citations

573

H-Index

13

Active since

2010

Affiliations

Queen's University Belfast(Current)

Massachusetts General Hospital

Harvard University

Royal College of Surgeons in Ireland

Christopher McCann is an author at Queen's University Belfast specializing in oncology, obstetrics, and gynecology oncology.

ORCID

Top concepts

Publications per year

2010–2021

15

Publications

15

Inhibition of Hedgehog Signaling Antagonizes Serous Ovarian Cancer Growth in a Primary Xenograft Model

Christopher McCann, Whitfield B. Growdon, Kashmira Kulkarni‐Datar et al. · PLoS ONE · 2011 · 88 citations · Full text

Surgical debulking of ovarian cancer: what difference does it make?

John O. Schorge, Christopher McCann, Marcela G. del Carmen · PubMed · 2010 · 76 citations · Full text

, , +12

Transcriptional Subtyping and CD8 Immunohistochemistry Identifies Patients With Stage II and III Colorectal Cancer With Poor Prognosis Who Benefit From Adjuvant Chemotherapy

Wendy L. Allen, Philip D. Dunne, Simon S. McDade et al. · JCO Precision Oncology · 2018 · 69 citations · Full text

A revised model of <scp>TRAIL</scp> ‐R2 <scp>DISC</scp> assembly explains how <scp>FLIP</scp> (L) can inhibit or promote apoptosis

Luke Humphreys, Jennifer Fox, Catherine Higgins et al. · EMBO Reports · 2020 · 55 citations · Full text

Prognostic determinants in patients with stage IIIC and IV uterine papillary serous carcinoma

J. Alejandro Rauh‐Hain, Whitfield B. Growdon, John O. Schorge et al. · Gynecologic Oncology · 2010 · 46 citations

, , +8

Rows per page

1–5 of 15